Since 2019, the HPV working group of the University of Virginia Cancer Center's Southwest Virginia Community Advisory Board has developed and executed strategi…

Human Papillomavirus InfectionVaccination Hesitancy

~Estimated

~$10 – $6,250

University of VirginiaNCT05860725

Phase 2

Neoadjuvant Chemotherapy and PD-1 Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

The NeoScorch HN study is a single institution multisite phase II trial including 3 cohorts of 25 patients each for patients with newly diagnosed locoregionall…

Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+6 more

~Estimated

~$10 – $6,250

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07209189

← PreviousPage 3 of 3Next →